GeneticsbioRxivPreprint
Ripply3 overdosage induces mid-face shortening through Tbx1 downregulation in Down syndrome models.
José Tomás Ahumada Saavedra, Claire Chevalier, Agnès Bloch‐Zupan, Yann Hérault
This study identifies Ripply3 overdosage as a cause of mid-face shortening in Down syndrome models through Tbx1 downregulation during branchial arch development.
1 citation